- Home
- Automated
- List of product information
- PDP-ISONIAZID TABLET 300 MG [SIN06651P]
PDP-ISONIAZID TABLET 300 MG [SIN06651P]
Active ingredients: PDP-ISONIAZID TABLET 300 MG
Product Info
PDP-ISONIAZID TABLET 300 MG
[SIN06651P]
Product information
Active Ingredient and Strength | ISONIAZID - 300 MG |
Dosage Form | TABLET |
Manufacturer and Country | PHARMASCIENCE INC. - CANADA |
Registration Number | SIN06651P |
Licence Holder | MEDICELL PHARMACEUTICAL (S) PTE. LTD. |
Forensic Classification | PRESCRIPTION ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | J04AC01 |
INDICATIONS
Used in conjunction with other antituberculosis drugs in the treatment of pulmonary and extrapulmonary tuberculosis and alone in the prophylaxis of tuberculosis.
DOSAGE
Orally as a single daily dose, preferably on an empty stomach. Absorption may be reduced with food but isoniazid may be taken with meals if gastrointestinal irritation occurs. May be given i.m. (if oral administration is not possible).
For treatment of active tuberculosis, adults, 5 to 10mg/kg daily in a single dose (maximum of 300mg daily) and rifampin (10 to 20mg/kg daily to a maximum of 600mg daily) which are administered for an initial phase lasting from 2 to 8 weeks.
Children inactivate isoniazid faster than adults and may be given 10 to 20 mg/kg daily in a single dose (up to 300 to 500mg daily).
For prophylactic use, isoniazid is generally used alone and preventive therapy generally should be continued for 6 months to 12 months.
Adults: 300 mg daily in a single dose. Children: 10 mg/kg daily in a single dose (maximum 300 mg daily).
Supplied: White tablet scored on one side, pms on the other side in 50, 100 and 300 mg. Bottles of 100.
CONTRAINDICATIONS
Patients who develop severe hypersensitivity reactions to isoniazid, included drug induced hepatitis; acute liver disease of any etiology, pregnancy (preventive treatment with isoniazid should be started after delivery).
